-
cells. Compounds identified through a pharmacological screening approach represent promising therapeutic leads, including in models of bortezomib-resistant cell lines. The project combines a fundamental
-
approach combines deep phenotyping approach and multimodal imaging in the EXPLORE task5. We collected data from 16 participants who participated in one behavioral session, two 7T fMRI sessions, and two MEG
-
approaches, combining epigenetic-focused themes as well as human systems, mouse models and innovative methods to investigate the causes of blood cancer and enhance the applicability of epigenetic therapies and
Searches related to combinators
Enter an email to receive alerts for combinators positions